The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-amino-8-(beta-D-ribofuranosyl)imidazo[1,2-a]-s-triazin-4-one 5'-monophosphate ID: ALA3275942
Cas Number: 67410-66-6
PubChem CID: 90679295
Max Phase: Preclinical
Molecular Formula: C10H14N5O8P
Molecular Weight: 363.22
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Nc1nc(=O)n2ccn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c2n1
Standard InChI: InChI=1S/C10H14N5O8P/c11-8-12-9-14(1-2-15(9)10(18)13-8)7-6(17)5(16)4(23-7)3-22-24(19,20)21/h1-2,4-7,16-17H,3H2,(H2,11,13,18)(H2,19,20,21)/t4-,5-,6-,7-/m1/s1
Standard InChI Key: PHYKWIBWRMBPJM-DBRKOABJSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
6.4727 -15.6340 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
6.4823 -16.4588 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.1918 -16.0382 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.6313 -10.9821 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
5.6302 -11.8094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3449 -12.2222 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.3431 -10.5694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.0583 -10.9784 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.0586 -11.8094 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8490 -12.0660 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.3373 -11.3935 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.8485 -10.7215 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.9154 -12.2213 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
6.3406 -9.7445 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.1041 -12.8504 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.6216 -13.5184 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.1067 -14.1856 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8912 -13.9304 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8909 -13.1056 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.7017 -14.9054 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.8768 -14.9149 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.6105 -12.7031 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.6164 -14.3243 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.6478 -15.6436 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
1 3 1 0
4 5 2 0
5 6 1 0
6 9 2 0
8 7 1 0
7 4 1 0
8 9 1 0
9 10 1 0
10 11 1 0
11 12 2 0
12 8 1 0
5 13 1 0
7 14 2 0
15 10 1 1
15 16 1 0
16 17 1 0
17 18 1 0
18 19 1 0
19 15 1 0
17 20 1 1
20 21 1 0
19 22 1 6
18 23 1 6
21 1 1 0
1 24 2 0
M END Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 363.22Molecular Weight (Monoisotopic): 363.0580AlogP: -2.80#Rotatable Bonds: 4Polar Surface Area: 194.66Molecular Species: ACIDHBA: 11HBD: 5#RO5 Violations: 1HBA (Lipinski): 13HBD (Lipinski): 6#RO5 Violations (Lipinski): 2CX Acidic pKa: 1.22CX Basic pKa: 3.05CX LogP: -2.79CX LogD: -6.22Aromatic Rings: 2Heavy Atoms: 24QED Weighted: 0.35Np Likeness Score: 0.81
References 1. Kim SH, Bartholomew DG, Allen LB, Robins RK, Revankar GR.. (1978) Imidazo[1,2-a]-s-triazine nucleosides. Synthesis and antiviral activity of the N-bridgehead guanine, guanosine, and guanosine monophosphate analogues of imidazo[1,2-a]-s-triazine., 21 (9): [PMID:214563 ] [10.1021/jm00207a009 ]